BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
BeOne Medicines
Study ID
NCT07492641
Phase
PHASE3
Status
Recruiting

Conditions

  • HR+/HER2- Breast Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • BGB-43395 — DRUG
    Administered orally.
  • Letrozole — DRUG
    Administered orally.
  • Abemaciclib — DRUG
    Administered orally.
  • Palbociclib — DRUG
    Administered orally.
  • Ribociclib — DRUG
    Administered orally.

Study Details

The purpose of this study is to investigate the efficacy and safety of BGB-43395 in combination with letrozole compared with investigator's choice of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) in combination with letrozole in patients with advanced or metastatic hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer (BC) who have not received prior systemic treatment for advanced or metastatic disease.

Key Dates

First listed
Mar 25, 2026
Start date
May 22, 2026
Status verified
Aug 2026
Primary completion
Apr 30, 2029
Completion
Aug 7, 2037

Study Design

Enrollment
1,056 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A: BGB-43395 + Letrozole
    Participants will receive BGB-43395 in combination with letrozole.
  • Active Comparator: Arm B: Cyclin-Dependent Kinase 4/6 Inhibitor + Letrozole
    Participants will receive either abemaciclib, palbociclib, or ribociclib based on the Investigator's choice in combination with letrozole.

Primary Outcome Measure

Progression-Free Survival (PFS) Determined by Blinded Independent Central Review (BICR) [ Time Frame: Up to approximately 4 years ]

Central Contacts

Locations (36)

FacilityCityStateZIPSite coordinators
Alabama Oncology PrincetonBirminghamAlabama35211-
Alaska Oncology and Hematology, LlcAnchorageAlaska99508-2974-
Ironwood Cancer and Research Centers Chandler IiChandlerArizona85224-5665-
Genesis Cancer and Blood Institute Hot Springs (Harmony Park)Hot SpringsArkansas71913-
Helios Clinical Research the Oncology Institute Fountain ValleyFountain ValleyCalifornia92708-
Ventura County Hematology Oncology SpecialistsOxnardCalifornia93030-
Brcr Coral SpringsCoral SpringsFlorida33065-
Mid Florida Hematology and Oncology CenterOrange CityFlorida32763-8316-
Florida Clinical Trials Group PlantationPlantationFlorida33322-
Hematology Oncology Associates of the Treasure CoastPort Saint LucieFlorida34952-7596-
Florida Clinical Trials Group TamaracTamaracFlorida33321-
Hope and Healing Cancer ServicesHinsdaleIllinois60521-0509-
Cancer Care Specialists For IllinoisOFallonIllinois62269-
Fort Wayne Medical Oncology and HematologyFort WayneIndiana46804-
Mercy Medical CenterCedar RapidsIowa52403-
Owensboro Health Mitchell Memorial Cancer CenterOwensboroKentucky42303-
Metro Minnesota Community Oncology Research Consortium (Mmcorc)Saint PaulMinnesota55101-2502-
Nebraska Cancer Specialists St Francis Grand IslandGrand IslandNebraska68803-
Cancer Partners of Nebraska April Sampson Cancer CenterLincolnNebraska68516-
Nebraska Cancer SpecialistsOmahaNebraska68130-2042-
Renown Regional Medical CenterRenoNevada89502-
Astera Cancer Care East BrunswickEast BrunswickNew Jersey08816-4096-
Summit Medical GroupFlorham ParkNew Jersey07932-1049-
New York Cancer and Blood SpecialistsShirleyNew York11967-
Pardee Cancer CenterHendersonvilleNorth Carolina28739-
Carolina Cancer Research CenterWilsonNorth Carolina27896-
Gabrail Cancer Center ResearchCantonOhio44718-2566-
Dayton Physicians NetworkDaytonOhio45409-
Oregon Oncology SpecialistsSalemOregon97301-
McGlinn Cancer InstituteWest ReadingPennsylvania19611-2143-
Ballad Health Cancer Center KingsportKingsportTennessee37660-
Virginia Cancer InstituteRichmondVirginia23229-8605-
Multicare Cancer Institute Deaconess Medical Office Building 1SpokaneWashington99204-
Multicare Cancer Institute Tacoma General HospitalTacomaWashington98405-
Northwest Medical SpecialtiesTacomaWashington98405-
Multicare Cancer Institute North Star LodgeYakimaWashington98902-

Find similar trials in Birmingham, AL

Related Studies